Heads the Regulatory & Compliance pillar at Lallemand Health Solutions, bringing together Global Regulatory Affairs, Scientific Affairs and Quality Assurance business interface, who ensures Lallemand probiotics access worldwide markets with the most effective, compliant and competitive strategy.Leads Regulatory Committees, working groups and initiatives advocating for probiotics before health authorities and calling for consistent and balanced regulatory approaches to provide a large choice of safe and efficacious probiotics to the consumers across the globe.External and Government affairs include,- Board of Directors (IPA and IPA EU); secretary - Chair of the Regulatory Committee IPA (Global) and co-Chair of the joint regulatory committee between the IPA and the Korean Society of Lactic acid Bacteria and Probiotics (S.Korea)- Board of Directors and Committees IFAC and FHCP (US & Canada)- Chair of the probiotics working group at GRMA (US)-Compli Committee NPA - Board SSCI (US)-involved in many trade associations direct or through the team, among which EHPM (Europe), Synadiet (FRANCE), EFFCA (Europe), BRAZIL and China